Jagsonpal Pharmaceuticals Share Price

    NSE
    241
    +10.62 (4.67%)
    JAGSNPHARM • 11 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    72.54%

    3Y Annualised Return

    17.91%

    5Y Annualised Return

    68.24%

    The current prices are delayed, login or Open Demat Account for live prices.

    Jagsonpal Pharmaceuticals Stock Performance

    1W Return4.76
    1Y Return81.31
    Today's Low226
    Prev. Close230.38
    Mkt Cap (Cr.)1,610.54
    1M Return1.66
    3Y Return77.10
    52-Week High328.04
    Open230.37
    PE Ratio40.58
    6M Return13.28
    Today's High249
    52-Week Low132.4
    Face Value2

    Jagsonpal Pharmaceuticals Company background

    Founded in: 1978
    Managing director: Manish Gupta
    Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multipurpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.The company has a strategic alliance with Fidia Spa, Italy and B Spofola, Czechoslovakia to manufacture sophisticated drugs in India. It has tied up with another Israelbased company, Makhteshim Chemical Works, for acquiring the marketing rights of an antioxidant product. In 1994, the company has also promoted Aresco Financial Services, a new financial company.The Companys RD activities have resulted in manufacturing process upgradation, improving packaging, and cost containment. Its RD activities are geared towards development of new product technologies which can be commercialised in future.It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia.In the fiscal 2001, the companys sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds, such as, sluggish market trends, lower growth rate of the industry and severe competition from drug majors. However the company has introduced various measures to counter the above factors so as to achieve continued growth and opportunity.The new manufacturing facility at Pantnagar, Uttarakhand started production in April 2009. The Company launched two brands, Divatrone and ProRetro in the market segment, Dydrogesterone, which was earlier dominated by a global pharma Company in August, 2021.On June 27, 2022, Infinity Holdings, an Indiafocused investment group acquired control over the Company consequent to acquisition of 43.73% of equity capital and became Promoters of the Company. The Company identified several products as part of new launches such as Indocap Gel, Lycored Plus, MemUp, Queezy ER to enhance healthcare professionals confidence and improve patient outcomes in 202324. It acquired the India and Bhutan business of Yash Pharma in May, 2024.

    As of 11 Jul, 2025, Jagsonpal Pharmaceuticals share price is ₹242.1. The stock opened at ₹230.4 and had closed at ₹230.4 the previous day. During today’s trading session, Jagsonpal Pharmaceuticals share price moved between ₹226.00 and ₹249.00, with an average price for the day of ₹237.50. Over the last 52 weeks, the stock has recorded a low of ₹132.40 and a high of ₹328.04. In terms of performance, Jagsonpal Pharmaceuticals share price has increased by 13.3% over the past six months and has increased by 72.54% over the last year.

    Read More
    Jagsonpal Pharmaceuticals SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹95,55,904 (+47.01%)
    Daily SIP of 25,000 would have become 95,55,904 in 1 year with a gain of 30,55,904 (+47.01%)
    View details of Market Depth

    Jagsonpal Pharmaceuticals Fundamental

    Market Cap (in crs)

    1,610.54

    Face Value

    2

    Turnover (in lacs)

    2,089.44

    Key Metrics

    Qtr Change %
    26.20% Fall from 52W High
    14.9
    Dividend yield 1yr %
    Below industry Median
    0.8

    Top Mutual Fund Invested in Jagsonpal Pharmaceuticals

    Promoter
    67.8%
    Foreign Institutions
    2.1%
    Public
    30.1%
    Promoter
    67.8%
    Foreign Institutions
    2.1%
    Public
    30.1%
    Promoter
    68%
    Foreign Institutions
    2.3%
    Mutual Funds
    0.1%
    Domestic Institutions
    0.1%
    Public
    29.6%
    Promoter
    68%
    Foreign Institutions
    1.1%
    Domestic Institutions
    0.8%
    Public
    30%
    Promoter
    68.1%
    Foreign Institutions
    0.7%
    Domestic Institutions
    0.9%
    Public
    30.3%
    Promoter
    68.5%
    Foreign Institutions
    0.5%
    Domestic Institutions
    0.9%
    Public
    30.2%

    Jagsonpal Pharmaceuticals Technical Analysis

    Moving Averages Analysis
    241
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    233.90
    10Day EMA
    230.80
    12Day EMA
    230.10
    20Day EMA
    228.40
    26Day EMA
    227.70
    50Day EMA
    226.30
    100Day EMA
    224.80
    200Day EMA
    215.60
    5Day SMA
    232.60
    10Day SMA
    230.40
    20Day SMA
    225.20
    30Day SMA
    227.80
    50Day SMA
    225.30
    100Day SMA
    221.90
    150Day SMA
    230.90
    200Day SMA
    225.90
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    252816 Rs
    936443 Rs
    Week Rs
    73055 Rs
    229455 Rs
    Month Rs
    52259 Rs
    125446 Rs
    239.03
    Pivot
    Resistance
    First Resistance
    252.06
    Second Resistance
    262.03
    Third Resistance
    275.06
    Support
    First Support
    229.06
    Second support
    216.03
    Third Support
    206.06
    Relative Strength Index
    66.74
    Money Flow Index
    91.07
    MACD
    2.38
    MACD Signal
    0.82
    Average True Range
    8.63
    Average Directional Index
    12.83
    Rate of Change (21)
    3.01
    Rate of Change (125)
    4.62

    Jagsonpal Pharmaceuticals Latest News

    08 JUL 2025 | Tuesday

    Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Cessation

    07 JUL 2025 | Monday

    Jagsonpal Pharmaceuticals Ltd - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    26 JUN 2025 | Thursday

    Jagsonpal Pharmaceuticals Ltd - 507789 - Closure of Trading Window

    View More

    Jagsonpal Pharmaceuticals Share Price FAQs

    Jagsonpal Pharmaceuticals share price is ₹241 in NSE and ₹241 in BSE as on 11/7/2025.

    Jagsonpal Pharmaceuticals share price in the past 1-year return was 81.31. The Jagsonpal Pharmaceuticals share hit a 1-year low of Rs. 132.4 and a 1-year high of Rs. 328.04.

    The market cap of Jagsonpal Pharmaceuticals is Rs. 1610.54 Cr. as of 11/7/2025.

    The PE ratios of Jagsonpal Pharmaceuticals is 40.58 as of 11/7/2025.

    The PB ratios of Jagsonpal Pharmaceuticals is 6.72 as of 11/7/2025

    You can easily buy Jagsonpal Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Jagsonpal Pharmaceuticals share price is ₹328.04 and ₹132.4 as of 11/7/2025.

    Please be aware that Jagsonpal Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.92
    -0.05 (-0.08%)
    135.28
    -1.85 (-1.35%)
    681.80
    -13.80 (-1.98%)
    2,558.70
    -22.30 (-0.86%)
    160.00
    -9.64 (-5.68%)
    381.65
    -3.05 (-0.79%)
    159.84
    -0.82 (-0.51%)
    263.35
    +0.50 (+0.19%)
    409.30
    -4.20 (-1.02%)
    396.85
    -3.05 (-0.76%)
    Top Gainers
    2,519.60
    +111.20 (+4.62%)
    1,835.20
    +25.00 (+1.38%)
    1,173.80
    +9.50 (+0.82%)
    2,220.60
    +16.80 (+0.76%)
    858.85
    +6.00 (+0.70%)
    Top Losers
    3,266.00
    -116.00 (-3.43%)
    3,073.20
    -89.20 (-2.82%)
    8,067.00
    -218.00 (-2.63%)
    258.30
    -6.75 (-2.55%)
    4,218.70
    -102.60 (-2.37%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -